Table 1.
Summary of case reports on atypical fractures in patients with multiple myeloma treated with bisphosphonates therapy.
| Author and year | Age (yr) | Sex | Fracture side | Duration of treatment with bisphosphonates (mo) | Number of bisphosphonate doses |
|---|---|---|---|---|---|
| Grasko et al., 2009 [15] | 66 | M | L | 96 | 88 (47 pamidronate, 41 zoledronate) |
|
| |||||
| Puhaindran et al., 2011 [16] | 64 | F | R | 103 | 58 (all pamidronate) |
|
| |||||
| Chang et al., 2012 [17] | N/A | N/A | Bilateral | N/A | N/A (pamidronate and/or zoledronate) |
| N/A | N/A | Bilateral | N/A | N/A (pamidronate and/or zoledronate) | |
|
| |||||
| Present case (same patient) | 53 | F | R | 94 | 78 (70 incadronate, 8 zoledronate) |
| 56 | F | L | 130 | 90 (70 incadronate, 20 zoledronate) | |
M: male; F: female; R: right; L: left; N/A: not available.